About us
We develop new platform technologies to more effectively diagnose and treat cancer. We primarily develop molecular imaging and phototherapy agents as well as nature-inspired theranostic nanomedicines, with a focus on creating clinically translatable technologies.
Our former postdoc, Miffy, led work on developing a theranostic nanoparticle for PSMA-targeted SPECT imaging and photodynamic therapy. Her recent paper was selected for a supplementary cover 🙌🎉🙌 @ACSBioMed @ACS4Authors. Read her paper here: https://t.co/xIXYPNVoY7 #MyACSCover https://t.co/Zbai2yIRMg
